| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |